Dynamic inositol pyrophosphate synthesis is a targetable therapeutic opportunity in ovarian cancer
Daniel P. Bondeson, David Husselbee, Saoirse Hanbury, Amirshayan Chadeganipour et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Nancy Dumont
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
141Publications signalées
6730Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Cancer-related Molecular PathwaysTGF-β signaling in diseasesMonoclonal and Polyclonal Antibodies ResearchUbiquitin and proteasome pathwaysHER2/EGFR in Cancer Research
Publications récentes
Supplemental Table 1 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Figure 6 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Figure 1 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Table 4 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Figure 5 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Table 3 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Figure 3 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Table 5 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Figure 7 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Figure 4 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
Supplemental Table 2 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.